含有化芳香成分的11-阿扎尔特米西宁衍生物:具有高瘤选择性的强效抗癌剂
Dung Tien Nguyen1, Thuong Hanh Ngo1, Mai Thanh Tran1
1Vietnam University of Traditional Medicine, No. 2 Tran Phu St., Ha Dong, Hanoi 12110, Viet Nam.
Bioorganic & medicinal chemistry letters
|September 19, 2024
概括
新的化11-azaartemisinin衍生物显示出强大的抗癌活性. m-衍生物 (8c) 显示出显著的瘤选择性,有效地抑制癌细胞生长,同时保护正常细胞.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 药理学 药理学是指药理学的学科.
背景情况:
- 素衍生物具有抗癌潜力.
- 芳香结构的化可以增强药物特性,如效力和选择性.
- 1,2,3-三连接在药物设计中是有用的.
研究的目的:
- 合成新型的11-azaartemisinin衍生物与基芳香基.
- 评估这些化合物对人类瘤细胞系的抗癌活性.
- 评估最强效衍生物的瘤选择性.
主要方法:
- 合成11-azaartemisinin衍生物,其中含有由1,2,3-triazoles连接的基芳香分子.
- 针对表皮癌 (KB),肝细胞癌 (HepG2) 和肺腺癌 (A549) 细胞系的体外抗增殖试验.
- 在正常人类胚胎 (Hek293) 细胞中对细胞毒性的评估.
主要成果:
- 六种合成的化合物 (8c-h) 在低微分子范围内表现出良好的抗增殖活性.
- 甲基 (8c) 和甲基 (8d) 衍生物表现出比其他基相似物更高的活性.
- 化合物8c表现出显著的瘤选择性,与癌细胞相比,对正常细胞的活性明显较低.
结论:
- 新型化11-azaartemisinin衍生物具有显著的抗癌特性.
- 甲衍生物 (8c) 是一个非常有前途的候选因其强大和选择性的抗瘤活性.
- 对化合物8c进行进一步的研究是有必要的,因为它具有治疗潜力.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
236
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
236
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
181
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
181
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
2.6K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.6K
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
835
Adrenergic antagonists, or sympatholytics, inhibit adrenoceptor activation driven by catecholamines or agonists. Based on their adrenoceptor specificity, adrenergic blockers can be categorized into two primary groups: α-adrenergic blockers (α-blockers) and β-adrenergic blockers (β-blockers). α-blockers interact with α1 and α2 subtypes of α-adrenoceptors.
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
835
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


